Stroke Trial, Recruiting NCT06741475 Sponsor: Taipei Medical University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06741475
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to give their informed consent to participate
  • People who have been diagnosed with an ischemic stroke (caused by a blocked blood vessel) and/or a hemorrhagic stroke (caused by bleeding in the brain)
  • People whose stroke-related disability falls within a moderate range, as measured by a standard medical scale called the Modified Rankin Scale (scores of 2 to 4)
  • People who are currently attending rehabilitation sessions fewer than 3 days per week
  • People who have a healthy caregiver available to support them

Who may not be able to join:

  • People who are currently receiving palliative (end-of-life comfort) care
  • People who have a major illness or serious condition that could affect their ability to take part — for example, a complete inability to understand or use language (global aphasia), dementia, multiple organ failure, or being unable to move due to a fracture (confirm with trial site for other conditions that may apply)
  • People with moderate cognitive (thinking and memory) difficulties after their stroke, specifically a score below 22 on a standard memory and thinking test called the Montreal Cognitive Assessment
  • People whose level of disability before their stroke was already above a certain point (a Modified Rankin Scale score greater than 1 before the stroke occurred)
  • People who are currently taking part in another clinical intervention study at the same time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Feng-Heng Chang, ScD, Graduate Institute of Injury Prevention and Control, Taipei Medical University

Phone: +886-2-66202589

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Taipei Medical University
Registry
ClinicalTrials.gov
Start date
4 February 2025
Est. completion
30 June 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Activity Measure for Post-Acute Care (AM-PAC) Outpatient Short Forms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov